UK is first country to approve Moderna omicron-targeted vaccine
Aug 15, 2022
The updated vaccine is expected to have a “important role” in protecting people from COVID-19 this winter.
Levetiracetam well-tolerated for Alzheimer’s disease
Oct 01, 2021
It does not improve primary outcome but did improve performance on certain cognitive tasks in those with epileptiform activity.
Higher habitual coffee intake may slow cognitive decline
Nov 30, 2021
Higher baseline coffee consumption also was linked to slower Aβ-amyloid accumulation during a 126-month study period, as shown on brain MRI scans.
Moderna begins testing booster shot aimed at omicron
Jan 27, 2022
The new study will focus on a single omicron-specific booster dose in about 600 adults.
Hypertension, type 2 diabetes contribute to brain changes in Puerto Rican seniors
Apr 01, 2022
A high prevalence of hypertension and type 2 diabetes was seen among the Puerto Rican cohort; those with both have deteriorating patterns in major white matter tracts.
Expiration dates on Johnson & Johnson COVID-19 vaccine extended
Jun 11, 2021
The FDA has added six weeks based on data from the company’s ongoing studies on the vaccine’s stability.
Nearly 200,000 COVID-19 home tests recalled over false positives
Oct 06, 2021
The problem with the Ellume rapid antigen tests was caused by variations in the quality of one of the raw materials used in the products.
Pfizer says new COVID-19 pill cuts severe disease by 89 percent
Nov 05, 2021
The drug is designed to prevent the coronavirus from making copies of itself.
Recommendations updated for management of heart failure
Apr 08, 2022
Sodium-glucose cotransporter-2 inhibitors are recommended for heart failure with reduced, mildly reduced ejection fraction.
Pfizer asks FDA for emergency approval of its COVID-19 antiviral pill
Nov 16, 2021
The request comes shortly after clinical trial testing the drug was halted early due to overwhelming evidence of its effectiveness.